Two US-listed companies saw notable open-market insider buying filed on September 8, with executives putting their own money on the line.
UBER President and COO Andrew Gordon MacDonald filed purchases totalling roughly $5.3 million in Uber stock. The trades were executed on September 4 at around $75.65 per share. A sitting COO writing an eight-figure personal cheque — across two separate purchases on the same day — is a clear show of confidence. Uber's market cap sits at around $145 billion, with short interest a modest 2.1% of free float.
On the same filing date, two directors at psychedelic biotech HELP (Cybin Inc.) disclosed combined purchases of roughly $2.4 million. Eric So bought $1.2 million worth, while Paul Glavine added $1.18 million. Both traded on September 3–4. Back-to-back director buying at a sub-$1 billion biotech is a strong signal. Cybin has short interest of 5.1% of free float.
Globally, ROBOTIS CEO Kim Byeong Soo filed a $75 million sale of his own company's South Korean-listed shares. That is among the largest C-level disposals reported on the date, though such a large founder sale often reflects diversification rather than a negative view on the business.
Private equity firm L Catterton also filed a $94 million exit from Italian cosmetics firm Intercos — a typical PE liquidity event.
This article is for informational purposes only and does not constitute financial advice.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
